In the latest trading session,, 1.67 million Intensity Therapeutics Inc (NASDAQ:INTS) shares changed hands as the company’s beta touched 4.33. With the company’s most recent per share price at $0.50 changing hands around $0.0 or -0.62% at last look, the market valuation stands at $9.20M. INTS’s current price is a discount, trading about -920.0% off its 52-week high of $5.10. The share price had its 52-week low at $0.29, which suggests the last value was 42.0% up since then.
Intensity Therapeutics Inc (NASDAQ:INTS) trade information
Instantly INTS was in red as seen in intraday trades today. With action 5.91%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -71.60%, with the 5-day performance at 5.91% in the green. However, in the 30-day time frame, Intensity Therapeutics Inc (NASDAQ:INTS) is -7.08% down.
The consensus price target for the stock as assigned by Wall Street analysts is 5, meaning bulls need an upside of 90.0% from its recent market value. According to analyst projections, INTS’s forecast low is 5 with 5 as the target high. To hit the forecast high, the stock’s price needs a -900.0% plunge from its current level, while the stock would need to soar -900.0% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.29%. The 2025 estimates are for Intensity Therapeutics Inc earnings to increase by 43.38%, but the outlook for the next 5-year period is at 17.65% per year.
INTS Dividends
Intensity Therapeutics Inc is expected to release its next quarterly earnings report in July.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 1.4948% or 0.2 million shares worth $1.0 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 190.07 shares estimated at $95606.0 under it, the former controlled 1.03% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.24% of the shares, roughly 43.6 shares worth around $21928.0.
